Identification of genes differentially expressed in benign versus malignant thyroid tumors - Wikidata - awgldk - TriplyDB

Identification of genes differentially expressed in benign versus malignant thyroid tumors

Identification of genes differentially expressed in benign versus malignant thyroid tumors

http://www.wikidata.org/entity/Q34913566

about

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer Identifying Cancer Biomarkers From Microarray Data Using Feature Selection and Semisupervised Learning.Thyroid nodule update on diagnosis and management.Decrease in thyroid adenoma associated (THADA) expression is a marker of dedifferentiation of thyroid tissue.Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid.Correlated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental models The Diagnostic Usefulness of HMGA2, Survivin, CEACAM6, and SFN/14-3-3 δ in Follicular Thyroid Carcinoma.Gene expression signature in endemic osteoarthritis by microarray analysis Three-gene molecular diagnostic model for thyroid cancer.MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.Molecular pathology of thyroid cancer: diagnostic and clinical implications.MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer Comparative analysis of signaling pathways in peripheral blood from patients with Kashin-Beck disease and osteoarthritis.Identification of benign and malignant thyroid nodules by in vivo iodine concentration measurement using single-source dual energy CT: A retrospective diagnostic accuracy study.Clinical implications of molecular markers in follicular cell-derived thyroid cancer.Diagnostic markers and prognostic factors in thyroid cancer.The quest for diagnostic molecular markers for thyroid nodules with indeterminate or suspicious cytology.Prediction of cancer outcome using DNA microarray technology: past, present and future.Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules.β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix A three-gene panel that distinguishes benign from malignant thyroid nodules.Integrated Bioinformatics Analysis of Potential Biomarkers for Prostate Cancer.Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.Molecular testing in the diagnosis of differentiated thyroid carcinomas

P2860

Q30367068-828D3F0D-CD0A-4FAA-81A4-1102EE0B89A4 Q31095580-15F7C17B-3F82-484F-8625-AA03AA0F941A Q33801964-AC1F8D27-3971-4A1C-844C-67A7F3C1E99B Q34066111-BBC96AF1-C643-4E5F-B986-BA2D4ACE4D71 Q34533693-A6436BE5-DD89-4A0F-AC0F-3DB229ACB725 Q35042608-6DD55D51-2F2B-484F-B930-206C91C45F5E Q35042618-DF66C468-00E1-4A05-BE46-8B9CE608E189 Q35091563-77EC46BF-2543-4293-9B90-789AC068C025 Q35198957-40B8D6F8-E132-45E4-A199-9ED1DADBD333 Q35723847-F85CF583-EC2F-4BAA-BD2C-0D618CA6F178 Q35778564-9C2F2441-21AD-4483-BF1F-58533936B6C4 Q36882561-A310B89E-6F33-483A-851A-B2244FDD1FD9 Q37337504-8CA226DF-2D73-4634-B21E-4AF797E22992 Q37447904-D68AA7C1-52A0-40A2-9044-5EBDE1CE3637 Q37569512-7BD84895-2C53-4AE5-9382-7FBD4D920690 Q37581675-E3DB98C4-62E8-4A17-9AA0-99673BE2F426 Q37605786-C23D66D7-18FF-4DEF-8B7C-EE2C500A5118 Q37611825-7B079E9F-6F85-4F10-8D61-A8AAE35C6A3E Q37620399-8EF759AE-76C2-4A51-BCE9-7098F87D3AC9 Q37996353-81DF3E41-8A82-40D3-8923-25A1074994D0 Q39998940-B049F191-AC8C-45E4-92E3-DC519E8C2CED Q40125465-995F08C8-D834-47D0-BF43-DB62C49DA411 Q40708235-BFC9BE12-AECA-4FD0-90BB-2E4608A894EA Q42734045-052C4C35-96D2-4221-BE8D-8BE1B8333C07 Q43729940-4DEC10BB-8E7A-4554-889D-1C31F5B6EF7A Q47272075-15A00303-B2E8-4BC1-976C-B90C29698A51 Q48035282-ACD8C7C2-7C30-4D70-AAA5-9D73D03B742C Q54976872-4610179F-BAA9-49E4-9A01-288F2D7BE31F Q58805430-111BCF36-8248-486F-B1FB-690661F5B4BD

P2860

Identification of genes differentially expressed in benign versus malignant thyroid tumors

http://www.wikidata.org/entity/Q34913566

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Identification of genes differ ...... ersus malignant thyroid tumors

@ast

Identification of genes differ ...... ersus malignant thyroid tumors

@en

Identification of genes differ ...... ersus malignant thyroid tumors

@nl

type

label

Identification of genes differ ...... ersus malignant thyroid tumors

@ast

Identification of genes differ ...... ersus malignant thyroid tumors

@en

Identification of genes differ ...... ersus malignant thyroid tumors

@nl

prefLabel

Identification of genes differ ...... ersus malignant thyroid tumors

@ast

Identification of genes differ ...... ersus malignant thyroid tumors

@en

Identification of genes differ ...... ersus malignant thyroid tumors

@nl

P1433

Q34913566-4FB56439-1F52-47E9-80F4-FDBAD85EE622

P1476

Q34913566-BFE2FAB2-0CB8-4C7D-9224-87E7288B6500

P2093

Q34913566-050E89EE-E39F-4B4B-9B02-9DF881398C97

Q34913566-2DDD8244-B84D-4504-BDEF-AC2063FA52C6

Q34913566-412990C3-2024-40DA-8773-84FEB826AB5A

Q34913566-52DA8862-0E79-40DE-8CB0-04BABB2CFFF4

Q34913566-676A0665-9E22-46CF-BEF2-55F8D53B4D4E

Q34913566-721BCA22-8653-4FCC-AD63-59B8F25BE76D

Q34913566-97E40FBE-E3DC-4096-837A-CDD9F88956B4

Q34913566-A3C2F915-5A2D-48D7-ACD8-36A40AE93C3A

Q34913566-AC4464C7-E2A5-4705-922B-188C02398D20

Q34913566-AF9D4DF5-3526-4766-93D6-6ED5A6584716

P2860

Q34913566-052096F4-0861-4D13-9EBD-367173FF1AEE

Q34913566-109B1999-14A5-41B2-80CA-C441BD914379

Q34913566-1D2653EC-018C-4A7F-ADD2-76780564A7DE

Q34913566-2195F268-E2A7-417E-A752-36AA5BC98973

Q34913566-27A663C5-E1D4-44ED-BAC5-94DE2006C570

Q34913566-2A6F1191-D348-413B-8028-F1A249FCD662

Q34913566-2FDCD8C9-8624-40F2-96EE-C6183F9C76A2

Q34913566-2FFE1B6D-1DD5-4ADC-82DA-02E13D09BCFC

Q34913566-3540A428-5D36-4DD4-9791-BD2C097312CF

Q34913566-358C1EEE-4BCA-4E0E-8230-E011D59AA388

P304

Q34913566-4C5F2296-796A-4337-ADAF-D3092F3DC4C1

P31

Q34913566-B1D89212-65FF-4187-B54D-1FEDB7AC1DF1

P356

Q34913566-A7060194-4D95-47F5-812F-0597306BD148

P407

Q34913566-B14E1225-6DFD-4030-B9ED-F4608B00C38F

P433

Q34913566-8CB861BF-AD42-4F5E-AAD3-AA0A663AE8F4

P478

Q34913566-5027ACE7-2E5C-4460-93FA-29B4CD5992A3

P577

Q34913566-2A066071-0EC5-48B5-A7FE-8777204A4DCC

P698

Q34913566-7764E733-1560-4591-B29C-05C1E647FC97

P932

Q34913566-8134E794-001E-4F43-922B-B5230556CB0B

P356

1078-0432.CCR-07-4495

P1433

Clinical Cancer Research

P1476

Identification of genes differ ...... ersus malignant thyroid tumors

@en

P2093

Alan P B Dackiw

http://www.w3.org/2001/XMLSchema#string

Christopher B Umbricht

http://www.w3.org/2001/XMLSchema#string

Douglas P Clark

http://www.w3.org/2001/XMLSchema#string

Helina Somervell

http://www.w3.org/2001/XMLSchema#string

Joseph A Califano

http://www.w3.org/2001/XMLSchema#string

Martha A Zeiger

http://www.w3.org/2001/XMLSchema#string

Michael R Marohn

http://www.w3.org/2001/XMLSchema#string

Nijaguna B Prasad

http://www.w3.org/2001/XMLSchema#string

Ralph P Tufano

http://www.w3.org/2001/XMLSchema#string

Steven K Libutti

http://www.w3.org/2001/XMLSchema#string

P2860

The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices

Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation

Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas

Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation

Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers

Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma

Multiclass cancer diagnosis using tumor gene expression signatures

Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers.

Practical methods for tissue microarray construction.

Genomic organization of the human SPOCK gene and its chromosomal localization to 5q31.

P304

3327-3337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-4495

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18519760

http://www.w3.org/2001/XMLSchema#string

P932

3086681

http://www.w3.org/2001/XMLSchema#string